[go: up one dir, main page]

BR0113372A - Composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos - Google Patents

Composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos

Info

Publication number
BR0113372A
BR0113372A BR0113372-1A BRPI0113372A BR0113372A BR 0113372 A BR0113372 A BR 0113372A BR PI0113372 A BRPI0113372 A BR PI0113372A BR 0113372 A BR0113372 A BR 0113372A
Authority
BR
Brazil
Prior art keywords
manufacture
pharmaceutical composition
modified carrier
composition
modified
Prior art date
Application number
BR0113372-1A
Other languages
English (en)
Inventor
Dirk L Teagarden
Scott A Brown
Nancy J Britten
James F Caputo
Leslie C Eaton
Ondrej Hendl
Syed F Huda
Harry M King
Susan M Machkovech
Randal Lee Schapaugh
Stanley M Speaker
Jean M Steele
Ching-Chiang Su
Terry R Urban
Niki A Waldron
Monica L Whitmire
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BRPI0113372A8 publication Critical patent/BRPI0113372A8/pt
Publication of BR0113372A publication Critical patent/BR0113372A/pt
Publication of BRPI0113372B1 publication Critical patent/BRPI0113372B1/pt
Publication of BRPI0113372B8 publication Critical patent/BRPI0113372B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA COM CARREADOR MODIFICADO, MéTODO DE FABRICAçãO DA MESMA E SEUS USOS". é propiciada uma composição caracterizada por compreender: (a) um ou mais agentes bioativos e (b) um carreador líquido modificado; em que, imediatamente a seguir à fabricação da composição, a referida composição pode ser administrada a um hospedeiro de modo que um ou mais dos agentes bioativos sejam liberados para o hospedeiro em uma base contínua.
BRPI0113372A 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur BRPI0113372B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23176700P 2000-09-12 2000-09-12
US60/231.767 2000-09-12
PCT/US2001/026013 WO2002022107A2 (en) 2000-09-12 2001-09-07 Pharmaceutical composition having modified carrier

Publications (4)

Publication Number Publication Date
BRPI0113372A8 BRPI0113372A8 (pt) 2003-06-24
BR0113372A true BR0113372A (pt) 2003-06-24
BRPI0113372B1 BRPI0113372B1 (pt) 2017-08-01
BRPI0113372B8 BRPI0113372B8 (pt) 2021-10-13

Family

ID=22870572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0113372A BRPI0113372B8 (pt) 2000-09-12 2001-09-07 composição veterinária com veículo modificado e ceftiofur

Country Status (18)

Country Link
US (1) US20020110561A1 (pt)
EP (1) EP1317256B1 (pt)
JP (1) JP4738713B2 (pt)
AR (2) AR030648A1 (pt)
AT (1) ATE412405T1 (pt)
AU (2) AU2001288323B2 (pt)
BR (1) BRPI0113372B8 (pt)
CA (1) CA2416566C (pt)
DE (1) DE60136367D1 (pt)
DK (1) DK1317256T3 (pt)
ES (1) ES2313981T3 (pt)
MX (1) MXPA03002055A (pt)
NZ (1) NZ524694A (pt)
PE (1) PE20030046A1 (pt)
PT (1) PT1317256E (pt)
TW (1) TWI284046B (pt)
WO (1) WO2002022107A2 (pt)
ZA (1) ZA200300617B (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006222A1 (en) 2009-07-17 2011-01-20 Cargill Agrícola S.A. Vegetable-fat food compound containing cottonseed oil

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
EP2367572B1 (en) * 2008-11-19 2018-08-29 Merial, Inc. Formulations comprising ceftiofur and benzyl alcohol
US9730884B2 (en) * 2011-09-29 2017-08-15 Plx Opco Inc. pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
MX388267B (es) 2014-11-19 2025-03-19 Univ Kansas State Mitigantes quimicos en alimento para animales e ingredientes alimentarios.
MA55205A (fr) 2019-03-06 2022-01-12 Zoetis Services Llc Formulations injectables prêtes à l'emploi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694419B2 (en) * 1993-03-12 1998-07-23 Zoetis P&U Llc Crystalline ceftiofur free acid
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006222A1 (en) 2009-07-17 2011-01-20 Cargill Agrícola S.A. Vegetable-fat food compound containing cottonseed oil

Also Published As

Publication number Publication date
AU2001288323B2 (en) 2006-11-23
AU8832301A (en) 2002-03-26
NZ524694A (en) 2005-05-27
DE60136367D1 (de) 2008-12-11
BRPI0113372B8 (pt) 2021-10-13
AR030648A1 (es) 2003-08-27
TWI284046B (en) 2007-07-21
DK1317256T3 (da) 2009-01-26
PT1317256E (pt) 2008-12-17
EP1317256B1 (en) 2008-10-29
BRPI0113372B1 (pt) 2017-08-01
JP2004508395A (ja) 2004-03-18
CA2416566C (en) 2011-05-31
MXPA03002055A (es) 2004-12-13
AR086688A2 (es) 2014-01-15
ATE412405T1 (de) 2008-11-15
ES2313981T3 (es) 2009-03-16
PE20030046A1 (es) 2003-02-14
BRPI0113372A8 (pt) 2003-06-24
WO2002022107A2 (en) 2002-03-21
EP1317256A2 (en) 2003-06-11
JP4738713B2 (ja) 2011-08-03
ZA200300617B (en) 2004-04-22
CA2416566A1 (en) 2002-03-21
WO2002022107A3 (en) 2003-01-16
US20020110561A1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR0202375A (pt) Composições farmacêutica compreendendo drogas e polìmeros de aumento da concentração
BR0109912A (pt) Novas combinações antelmìnticas
BR0113710A (pt) Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
CO4410203A1 (es) Formulaciones de analogos de insulina
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
BR9708632A (pt) Composto calcilìticos
AR035533A1 (es) Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
BR9915621A (pt) Revestimento útil como um distribuidor de um ingrediente ativo em curativos e ataduras
MX9207495A (es) Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
BR9713141A (pt) Composição farmcêutica processo e kit para o tratamento ou a prevenção de um quadro fisiológico asociado com um distúrbio isquêmico relacionado com trombose e um paciente, uso de quantidades farmaceuticamente efetivas de um composto com atividade anti-xa e de um composto antagonista de agregação de plaquetas, produto contendo estes compostos, e, uso destes compostos.
BR0113372A (pt) Composição farmacêutica com carreador modificado, método de fabricação da mesma e seus usos
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
BR9912218A (pt) Compostos obtidos de espécies de sálvia possuindo atividade antivirótica
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
BR0109602A (pt) Glóbulos de liberação controlada contendo estavudina
BR0114272A (pt) Formulação farmacêutica de liberação prolongada independente da força iÈnica

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: PHARMACIA AND UPJOHN COMPANY LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH PANDU LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS PANDU LLC (US)

B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2001, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2430 DE 01/08/2017 - PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/08/2017, OBSERVADAS AS CONDICOES LEGAIS. JUSTIFICATIVA DE RETIFICACAO: PATENTE RELACIONADA A PRODUTO VETERINARIO.